Back to DE Deerfield Management Company, L.P.
BRBridgebio Pharma Inc Note 2.500percent 3/1
Showing 0 of 6 quarters
Position history for DEDeerfield Management Company, L.P.'s holdings in Bridgebio Pharma Inc Note 2.500percent 3/1
No. Deerfield Management exited its Bridgebio Pharma Inc Note 2.500percent 3/1 position in Q2 2022. Its Q1 2022 13F listed 80,000,000 shares worth $47.4M. Deerfield Management held Bridgebio Pharma Inc Note 2.500percent 3/1 in 5 quarterly 13F filings before exiting.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
—
No position history available for this security.